Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Neurocrine Biosciences Inc..
Neurocrine Biosciences Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Neurocrine Biosciences Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Neurocrine Biosciences Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Neurocrine Biosciences Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Neurocrine Biosciences Inc. and all latest updates of the company are provided.
The 2025 version of Neurocrine Biosciences Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Neurocrine Biosciences Inc.- Key Facts
2.2 Neurocrine Biosciences Inc.- Geographic Locations
2.3 Neurocrine Biosciences Inc.- Subsidiaries and Affiliates
2.4 Neurocrine Biosciences Inc.- Business Divisions
2.5 Neurocrine Biosciences Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Neurocrine Biosciences Inc. Strategic Analysis Review
3.1 Neurocrine Biosciences Inc.- Key Strategies
3.2 Neurocrine Biosciences Inc.- Company Outlook Statement
3.3 Neurocrine Biosciences Inc.- SWOT Analysis
3.3.1 Neurocrine Biosciences Inc.- Key Strengths
3.3.2 Neurocrine Biosciences Inc.- Key Weaknesses
3.3.3 Neurocrine Biosciences Inc.- Potential Opportunities
3.3.4 Neurocrine Biosciences Inc.- Potential Threats
3.4 Neurocrine Biosciences Inc.- Key Competitors
4. Business Description of the Company
4.1 Neurocrine Biosciences Inc.- Business Overview
4.2 Neurocrine Biosciences Inc.- Operations by Segment
5 Products and Services Details
5.1 Neurocrine Biosciences Inc.- Key Products
5.2 Neurocrine Biosciences Inc.- Key Service Areas
5.3 Neurocrine Biosciences Inc.- Key Brands
6 Company Developments
6.1 Neurocrine Biosciences Inc.- Company History
6.2 Neurocrine Biosciences Inc.- Latest Developments
7 Financial Analysis
7.1 Neurocrine Biosciences Inc.- Income Statements
7.2 Neurocrine Biosciences Inc.- Balance Sheet
7.3 Neurocrine Biosciences Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Neurocrine Biosciences Inc.- Direct Competitors
8.2 Neurocrine Biosciences Inc.- Competitor Financial Ratios comparison
8.3 Neurocrine Biosciences Inc.- Competitor Stock Charts Comparison
8.4 Neurocrine Biosciences Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!